Cargando…

Sex differences in a double-blind randomized clinical trial with minocycline in treatment-resistant depressed patients: CRP and IL-6 as sex-specific predictors of treatment response

BACKGROUND: Inflammation is a well-known risk factor for depression. Specifically, patients who do not respond to antidepressant treatment show higher levels of inflammatory biomarkers compared with responders. Thus, several studies have investigated the efficacy of anti-inflammatory add-on treatmen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lombardo, Giulia, Nettis, Maria Antonietta, Hastings, Caitlin, Zajkowska, Zuzanna, Mariani, Nicole, Nikkheslat, Naghmeh, Worrell, Courtney, Enache, Daniela, McLaughlin, Anna, Kose, Melisa, Bogdanova, Anna, Sforzini, Luca, Cleare, Anthony J., Young, Allan H., Dazzan, Paola, Mondelli, Valeria, Pariante, Carmine M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Full Length Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9712814/ https://www.ncbi.nlm.nih.gov/pubmed/36467125 http://dx.doi.org/10.1016/j.bbih.2022.100561

Ejemplares similares

Augmentation therapy with minocycline in treatment-resistant depression patients with low-grade peripheral inflammation: results from a double-blind randomised clinical trial
por: Nettis, Maria Antonietta, et al.
Publicado: (2021)

The interaction between kynurenine pathway, suicidal ideation and augmentation therapy with minocycline in patients with treatment-resistant depression
por: Nettis, Maria Antonietta, et al.
Publicado: (2023)

Higher immune-related gene expression in major depression is independent of CRP levels: results from the BIODEP study
por: Sforzini, Luca, et al.
Publicado: (2023)

The influence of comorbid depression and overweight status on peripheral inflammation and cortisol levels
por: McLaughlin, Anna P., et al.
Publicado: (2022)

Whole-blood expression of inflammasome- and glucocorticoid-related mRNAs correctly separates treatment-resistant depressed patients from drug-free and responsive patients in the BIODEP study
por: Cattaneo, Annamaria, et al.
Publicado: (2020)

Correction: Whole-blood expression of inflammasome- and glucocorticoid-related mRNAs correctly separates treatment-resistant depressed patients from drug-free and responsive patients in the BIODEP study
por: Cattaneo, Annamaria, et al.
Publicado: (2020)

Childhood trauma, HPA axis activity and antidepressant response in patients with depression
por: Nikkheslat, Naghmeh, et al.
Publicado: (2020)

Using quantitative MRI to study brain responses to immune challenge with interferon-α
por: Nettis, Maria Antonietta, et al.
Publicado: (2021)

PET imaging shows no changes in TSPO brain density after IFN-α immune challenge in healthy human volunteers
por: Nettis, M. A., et al.
Publicado: (2020)

Inflammation in cancer and depression: a starring role for the kynurenine pathway
por: Sforzini, Luca, et al.
Publicado: (2019)

The Role of Peripheral Inflammation in Clinical Outcome and Brain Imaging Abnormalities in Psychosis: A Systematic Review
por: Kose, Melisa, et al.
Publicado: (2021)

Ketamine’s effect on inflammation and kynurenine pathway in depression: A systematic review
por: Kopra, Emma, et al.
Publicado: (2021)

Differential effect of interferon-alpha treatment on AEA and 2-AG levels
por: Zajkowska, Zuzanna, et al.
Publicado: (2020)

Persistent fatigue induced by interferon-alpha: a novel, inflammation-based, proxy model of chronic fatigue syndrome
por: Russell, Alice, et al.
Publicado: (2019)

Network analysis of inflammation and symptoms in recent onset schizophrenia and the influence of minocycline during a clinical trial
por: Herniman, Sarah E., et al.
Publicado: (2023)

Minocycline in Major Depressive Disorder: And overview with considerations on treatment-resistance and comparisons with other psychiatric disorders
por: Nettis, Maria Antonietta
Publicado: (2021)

Exploring the role of immune pathways in the risk and development of depression in adolescence: Research protocol of the IDEA-FLAME study
por: Mondelli, Valeria, et al.
Publicado: (2021)

Sex-independent neuroprotection with minocycline after experimental thromboembolic stroke
por: Hoda, Md Nasrul, et al.
Publicado: (2011)

The benefit of minocycline on negative symptoms of schizophrenia in patients with recent-onset psychosis (BeneMin): a randomised, double-blind, placebo-controlled trial
por: Deakin, Bill, et al.
Publicado: (2018)

The role of circulatory systemic environment in predicting interferon-alpha–induced depression: The neurogenic process as a potential mechanism
por: Borsini, Alessandra, et al.
Publicado: (2019)

Targeting inflammation in depression: Ketamine as an anti-inflammatory antidepressant in psychiatric emergency
por: Nikkheslat, Naghmeh
Publicado: (2021)

Early Life Social Stress Causes Sex- and Region-Dependent Dopaminergic Changes that Are Prevented by Minocycline
por: Catale, Clarissa, et al.
Publicado: (2022)

A Systematic Review of Cognitive Function in First-Episode Psychosis, Including a Discussion on Childhood Trauma, Stress, and Inflammation
por: Aas, Monica, et al.
Publicado: (2014)

T14. ASSESSING DIFFERENCES IN INFLAMMATORY MARKERS BETWEEN FIRST EPISODE PSYCHOSIS PATIENTS AND HEALTHY CONTROLS: THE IMPORTANCE OF CONTROLLING FOR CONFOUNDING FACTORS
por: Giordano, Annalisa, et al.
Publicado: (2018)

Peripheral immune markers and antipsychotic non-response in psychosis
por: Enache, Daniela, et al.
Publicado: (2021)

Crosstalk between endocannabinoid and immune systems: a potential dysregulation in depression?
por: Boorman, Emily, et al.
Publicado: (2015)

Transcriptomics in Interferon-α-Treated Patients Identifies Inflammation-, Neuroplasticity- and Oxidative Stress-Related Signatures as Predictors and Correlates of Depression
por: Hepgul, Nilay, et al.
Publicado: (2016)

Examination of sex and minocycline treatment on acute morphine-induced analgesia and inflammatory gene expression along the pain pathway in Sprague–Dawley rats
por: Posillico, Caitlin K., et al.
Publicado: (2015)

Haloperidol and olanzapine mediate metabolic abnormalities through different molecular pathways
por: Mondelli, V, et al.
Publicado: (2013)

Efficacy of Minocycline for the Treatment of Mycoplasma genitalium
por: Clarke, Emily J, et al.
Publicado: (2023)

Cause or consequence? Understanding the role of cortisol in the increased inflammation observed in depression
por: Amasi-Hartoonian, Nare, et al.
Publicado: (2022)

Antidepressant Compounds Can Be Both Pro- and Anti-Inflammatory in Human Hippocampal Cells
por: Horowitz, Mark Abie, et al.
Publicado: (2015)

Cognitive function in early-phase schizophrenia-spectrum disorder: IQ subtypes, brain volume and immune markers
por: Watson, Andrew J., et al.
Publicado: (2023)

In(s) and out(s) of adolescent depression – Trajectories of development and recovery
por: Zajkowska, Zuzanna
Publicado: (2021)

Structural Covariance of Cortical Gyrification at Illness Onset in Treatment Resistance: A Longitudinal Study of First-Episode Psychoses
por: Ajnakina, Olesya, et al.
Publicado: (2021)

Profile of minocycline and its potential in the treatment of schizophrenia
por: Zhang, Lulu, et al.
Publicado: (2014)

Minocycline-induced hyperpigmentation
por: Fiscus, Valena, et al.
Publicado: (2014)

What can neuroimmunology teach us about the symptoms of long-COVID?
por: Mondelli, Valeria, et al.
Publicado: (2021)

The Anticancer Potential of Doxycycline and Minocycline—A Comparative Study on Amelanotic Melanoma Cell Lines
por: Rok, Jakub, et al.
Publicado: (2022)

Minocycline and MMPs: towards treatment for Fragile X syndrome
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_htvo2v837ucs90niavtqe0ursr